CHANTILLY BIOPHARMA Trademark

Trademark Overview


On Friday, August 5, 2011, a trademark application was filed for CHANTILLY BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CHANTILLY BIOPHARMA trademark a serial number of 85390392. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 5, 2012. This trademark is owned by Chantilly bioPharma LLC. The CHANTILLY BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Balms for pharmaceutical purposes; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for active pharmaceuticals; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for pharmaceutical actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide c...
chantilly biopharma

General Information


Serial Number85390392
Word MarkCHANTILLY BIOPHARMA
Filing DateFriday, August 5, 2011
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 5, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"BIOPHARAMA"
Goods and ServicesAnalgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Balms for pharmaceutical purposes; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for active pharmaceuticals; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for pharmaceutical actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ferments for pharmaceutical purposes; Gelatin capsules sold empty for pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of colds and the flu; Hyaluronic acid for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical actives; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
Pseudo MarkCHANTILLY BIO PHARMA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2011
Primary Code005
First Use Anywhere DateSunday, March 20, 2011
First Use In Commerce DateSunday, March 20, 2011

Trademark Owner History


Party NameChantilly bioPharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChantilly, VA 20151

Trademark Events


Event DateEvent Description
Thursday, July 5, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, July 5, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 8, 2011COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Thursday, December 8, 2011ASSIGNED TO LIE
Thursday, December 8, 2011NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, December 8, 2011EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, December 8, 2011EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, November 30, 2011ASSIGNED TO EXAMINER
Wednesday, August 10, 2011NOTICE OF PSEUDO MARK MAILED
Tuesday, August 9, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 9, 2011NEW APPLICATION ENTERED IN TRAM